Cargando…

Resting Energy Expenditure, Insulin Resistance and UCP1 Expression in Human Subcutaneous and Visceral Adipose Tissue of Patients With Obesity

Determinants of resting energy expenditure (REE) in humans are still under investigation, especially the association with insulin resistance. Brown adipose tissue (AT) regulates energy expenditure through the activity of the uncoupling protein 1 (UCP1). White AT browning is the process by which some...

Descripción completa

Detalles Bibliográficos
Autores principales: Bettini, Silvia, Favaretto, Francesca, Compagnin, Chiara, Belligoli, Anna, Sanna, Marta, Fabris, Roberto, Serra, Roberto, Dal Prà, Chiara, Prevedello, Luca, Foletto, Mirto, Vettor, Roberto, Milan, Gabriella, Busetto, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692889/
https://www.ncbi.nlm.nih.gov/pubmed/31440209
http://dx.doi.org/10.3389/fendo.2019.00548
_version_ 1783443613724704768
author Bettini, Silvia
Favaretto, Francesca
Compagnin, Chiara
Belligoli, Anna
Sanna, Marta
Fabris, Roberto
Serra, Roberto
Dal Prà, Chiara
Prevedello, Luca
Foletto, Mirto
Vettor, Roberto
Milan, Gabriella
Busetto, Luca
author_facet Bettini, Silvia
Favaretto, Francesca
Compagnin, Chiara
Belligoli, Anna
Sanna, Marta
Fabris, Roberto
Serra, Roberto
Dal Prà, Chiara
Prevedello, Luca
Foletto, Mirto
Vettor, Roberto
Milan, Gabriella
Busetto, Luca
author_sort Bettini, Silvia
collection PubMed
description Determinants of resting energy expenditure (REE) in humans are still under investigation, especially the association with insulin resistance. Brown adipose tissue (AT) regulates energy expenditure through the activity of the uncoupling protein 1 (UCP1). White AT browning is the process by which some adipocytes within AT depots acquire properties of brown adipocytes (“brite” adipocytes) and it correlates with metabolic improvement. We analyzed determinants of REE in patients with obesity and assessed UCP1 expression as a “brite” marker in abdominal subcutaneous AT (SAT) and visceral omental AT (VAT). Clinical data, REE, free fat mass (FFM), and fat mass (FM) were determined in 209 patients with obesity. UCP1, PPARG coactivator 1 alpha (PPARGC1A), transcription factor A, mitochondrial (TFAM), T-box transcription factor 1 (TBX1), and solute carrier family 27 member 1 (SLC27A1) expression was assayed in SAT and VAT samples, obtained during sleeve gastrectomy from 62 patients with obesity. REE and body composition data were also available for a subgroup of 35 of whom. In 209 patients with obesity a multiple regression model was computed with REE as the dependent variable and sex, waist, FFM, FM, homeostasis model assessment-insulin resistance (HOMA), interleukin-6 and High Density Lipoprotein-cholesterol as the independent variables. Only FFM, FM and HOMA were independently correlated with REE (r = 0.787, AdjRsqr = 0.602). In each patient VAT displayed a higher UCP1, PPARGC1A, TFAM, TBX1, and SLC27A1 expression than SAT and UCP1 expression in VAT (UCP1-VAT) correlated with Body Mass Index (BMI) (r = 0.287, p < 0.05). Introducing UCP1-VAT in the multivariate model, we showed that FFM, HOMA, interleukin-6, High Density Lipoprotein-cholesterol, and UCP1-VAT were independent factors correlated with REE (r = 0.736, AdjRsqr = 0.612). We confirmed that REE correlates with FFM, FM and HOMA in a large cohort of patients. Our results clearly showed that UCP1-VAT expression was significantly increased in severe human obesity (BMI > 50 kg/m(2)) and that it behaved as an independent predictor of REE. Lastly, we suggest that an increased REE and browning in metabolically complicated severe obesity could represent an effort to counteract further weight gain.
format Online
Article
Text
id pubmed-6692889
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-66928892019-08-22 Resting Energy Expenditure, Insulin Resistance and UCP1 Expression in Human Subcutaneous and Visceral Adipose Tissue of Patients With Obesity Bettini, Silvia Favaretto, Francesca Compagnin, Chiara Belligoli, Anna Sanna, Marta Fabris, Roberto Serra, Roberto Dal Prà, Chiara Prevedello, Luca Foletto, Mirto Vettor, Roberto Milan, Gabriella Busetto, Luca Front Endocrinol (Lausanne) Endocrinology Determinants of resting energy expenditure (REE) in humans are still under investigation, especially the association with insulin resistance. Brown adipose tissue (AT) regulates energy expenditure through the activity of the uncoupling protein 1 (UCP1). White AT browning is the process by which some adipocytes within AT depots acquire properties of brown adipocytes (“brite” adipocytes) and it correlates with metabolic improvement. We analyzed determinants of REE in patients with obesity and assessed UCP1 expression as a “brite” marker in abdominal subcutaneous AT (SAT) and visceral omental AT (VAT). Clinical data, REE, free fat mass (FFM), and fat mass (FM) were determined in 209 patients with obesity. UCP1, PPARG coactivator 1 alpha (PPARGC1A), transcription factor A, mitochondrial (TFAM), T-box transcription factor 1 (TBX1), and solute carrier family 27 member 1 (SLC27A1) expression was assayed in SAT and VAT samples, obtained during sleeve gastrectomy from 62 patients with obesity. REE and body composition data were also available for a subgroup of 35 of whom. In 209 patients with obesity a multiple regression model was computed with REE as the dependent variable and sex, waist, FFM, FM, homeostasis model assessment-insulin resistance (HOMA), interleukin-6 and High Density Lipoprotein-cholesterol as the independent variables. Only FFM, FM and HOMA were independently correlated with REE (r = 0.787, AdjRsqr = 0.602). In each patient VAT displayed a higher UCP1, PPARGC1A, TFAM, TBX1, and SLC27A1 expression than SAT and UCP1 expression in VAT (UCP1-VAT) correlated with Body Mass Index (BMI) (r = 0.287, p < 0.05). Introducing UCP1-VAT in the multivariate model, we showed that FFM, HOMA, interleukin-6, High Density Lipoprotein-cholesterol, and UCP1-VAT were independent factors correlated with REE (r = 0.736, AdjRsqr = 0.612). We confirmed that REE correlates with FFM, FM and HOMA in a large cohort of patients. Our results clearly showed that UCP1-VAT expression was significantly increased in severe human obesity (BMI > 50 kg/m(2)) and that it behaved as an independent predictor of REE. Lastly, we suggest that an increased REE and browning in metabolically complicated severe obesity could represent an effort to counteract further weight gain. Frontiers Media S.A. 2019-08-07 /pmc/articles/PMC6692889/ /pubmed/31440209 http://dx.doi.org/10.3389/fendo.2019.00548 Text en Copyright © 2019 Bettini, Favaretto, Compagnin, Belligoli, Sanna, Fabris, Serra, Dal Prà, Prevedello, Foletto, Vettor, Milan and Busetto. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Bettini, Silvia
Favaretto, Francesca
Compagnin, Chiara
Belligoli, Anna
Sanna, Marta
Fabris, Roberto
Serra, Roberto
Dal Prà, Chiara
Prevedello, Luca
Foletto, Mirto
Vettor, Roberto
Milan, Gabriella
Busetto, Luca
Resting Energy Expenditure, Insulin Resistance and UCP1 Expression in Human Subcutaneous and Visceral Adipose Tissue of Patients With Obesity
title Resting Energy Expenditure, Insulin Resistance and UCP1 Expression in Human Subcutaneous and Visceral Adipose Tissue of Patients With Obesity
title_full Resting Energy Expenditure, Insulin Resistance and UCP1 Expression in Human Subcutaneous and Visceral Adipose Tissue of Patients With Obesity
title_fullStr Resting Energy Expenditure, Insulin Resistance and UCP1 Expression in Human Subcutaneous and Visceral Adipose Tissue of Patients With Obesity
title_full_unstemmed Resting Energy Expenditure, Insulin Resistance and UCP1 Expression in Human Subcutaneous and Visceral Adipose Tissue of Patients With Obesity
title_short Resting Energy Expenditure, Insulin Resistance and UCP1 Expression in Human Subcutaneous and Visceral Adipose Tissue of Patients With Obesity
title_sort resting energy expenditure, insulin resistance and ucp1 expression in human subcutaneous and visceral adipose tissue of patients with obesity
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692889/
https://www.ncbi.nlm.nih.gov/pubmed/31440209
http://dx.doi.org/10.3389/fendo.2019.00548
work_keys_str_mv AT bettinisilvia restingenergyexpenditureinsulinresistanceanducp1expressioninhumansubcutaneousandvisceraladiposetissueofpatientswithobesity
AT favarettofrancesca restingenergyexpenditureinsulinresistanceanducp1expressioninhumansubcutaneousandvisceraladiposetissueofpatientswithobesity
AT compagninchiara restingenergyexpenditureinsulinresistanceanducp1expressioninhumansubcutaneousandvisceraladiposetissueofpatientswithobesity
AT belligolianna restingenergyexpenditureinsulinresistanceanducp1expressioninhumansubcutaneousandvisceraladiposetissueofpatientswithobesity
AT sannamarta restingenergyexpenditureinsulinresistanceanducp1expressioninhumansubcutaneousandvisceraladiposetissueofpatientswithobesity
AT fabrisroberto restingenergyexpenditureinsulinresistanceanducp1expressioninhumansubcutaneousandvisceraladiposetissueofpatientswithobesity
AT serraroberto restingenergyexpenditureinsulinresistanceanducp1expressioninhumansubcutaneousandvisceraladiposetissueofpatientswithobesity
AT dalprachiara restingenergyexpenditureinsulinresistanceanducp1expressioninhumansubcutaneousandvisceraladiposetissueofpatientswithobesity
AT prevedelloluca restingenergyexpenditureinsulinresistanceanducp1expressioninhumansubcutaneousandvisceraladiposetissueofpatientswithobesity
AT folettomirto restingenergyexpenditureinsulinresistanceanducp1expressioninhumansubcutaneousandvisceraladiposetissueofpatientswithobesity
AT vettorroberto restingenergyexpenditureinsulinresistanceanducp1expressioninhumansubcutaneousandvisceraladiposetissueofpatientswithobesity
AT milangabriella restingenergyexpenditureinsulinresistanceanducp1expressioninhumansubcutaneousandvisceraladiposetissueofpatientswithobesity
AT busettoluca restingenergyexpenditureinsulinresistanceanducp1expressioninhumansubcutaneousandvisceraladiposetissueofpatientswithobesity